Literature DB >> 21994146

Broad-range bacterial polymerase chain reaction in the microbiologic diagnosis of complicated pneumonia.

Kandace Gollomp1, Shelley C Rankin, Caitlin White, Peter Mattei, Mary C Harris, Laurie E Kilpatrick, Seth Sheffler-Collins, Karin L McGowan, Samir S Shah.   

Abstract

BACKGROUND: A bacterial cause is not frequently identified in children with pneumonia complicated by parapneumonic effusion (ie, complicated pneumonia).
OBJECTIVES: To determine the frequency of positive blood and pleural fluid cultures in children with complicated pneumonia and to determine whether broad-range 16S rRNA polymerase chain reaction (PCR) improves identification of a microbiologic cause.
METHODS: This prospective cohort study included children 1-18 years of age hospitalized with complicated pneumonia.
RESULTS: Pleural fluid drainage was performed in 64 (51.6%) of 124 children with complicated pneumonia. A microbiologic cause was identified in 11 of 64 patients (17.2%; 95% confidence interval [CI]: 8.9%-28.7%). Bacteria were isolated from pleural fluid culture in 6 of 64 patients (9.4 %; 95% CI: 3.5%-19.3%) undergoing pleural drainage; the causative bacteria were Staphylococcus aureus (n = 5) and Streptococcus pneumoniae (n = 1). Blood culture identified a bacterial cause in 3 of 44 cases (6.8%; 95% CI: 1.4%-18.7%) undergoing pleural fluid drainage; S. pneumoniae (n = 1), Haemophilus influenzae (n = 1), and S. aureus (n = 1) were isolated. Only 3 of the 19 pleural fluid samples (15.8%; 95% CI: 3.4%-39.6%) analyzed with 16S rRNA PCR were positive. S. pneumoniae was the only organism detected in all three samples; two of these three had negative pleural fluid cultures and absence of bacteria on Gram stain. S. aureus was isolated from pleural fluid culture in one patient with a negative 16S rRNA PCR test.
CONCLUSIONS: Causative bacteria were infrequently identified in children with complicated pneumonia. Broad-range 16S rRNA PCR only modestly improved the microbiologic yield over conventional culture methods.
Copyright © 2011 Society of Hospital Medicine.

Entities:  

Keywords:  Staphylococcus aureus; Streptococcus pneumoniae; empyema; molecular diagnostic techniques; pneumonia, bacterial; polymerase chain reaction

Mesh:

Year:  2011        PMID: 21994146     DOI: 10.1002/jhm.911

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  6 in total

1.  Healthcare-associated pneumonia: a prospective study in Spain.

Authors:  P Llinares; M C Fariñas; F Arnaíz de Las Revillas; D Sousa; C Ardunay; C García-Vidal; M Montejo; R Rodríguez-Álvarez; J Pasquau; E Bouza; J A Oteo; C Balseiro; C Méndez; N Lwoff
Journal:  Rev Esp Quimioter       Date:  2020-07-22       Impact factor: 1.553

2.  Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture.

Authors:  Anne J Blaschke; Carrie L Byington; Krow Ampofo; Andrew T Pavia; Caroline Heyrend; Shelley C Rankin; Karin L McGowan; Mary C Harris; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2013-03       Impact factor: 2.129

3.  Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion.

Authors:  Léo Franchetti; Desiree M Schumann; Michael Tamm; Kathleen Jahn; Daiana Stolz
Journal:  BMC Infect Dis       Date:  2020-02-01       Impact factor: 3.090

4.  Community-Acquired Pneumonia in the Conjugate Vaccine Era.

Authors:  Derek J Williams; Samir S Shah
Journal:  J Pediatric Infect Dis Soc       Date:  2012-11-06       Impact factor: 3.164

5.  Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.

Authors:  Jeffrey M Pernica; Ioana Moldovan; Francis Chan; Robert Slinger
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-05       Impact factor: 2.471

6.  Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.

Authors:  Katarzyna Krenke; Ewa Sadowy; Edyta Podsiadły; Waleria Hryniewicz; Urszula Demkow; Marek Kulus
Journal:  Respir Med       Date:  2016-05-10       Impact factor: 3.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.